The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Allegra Orthopaedics (AMT) has started distributing Australian made and designed face shields to front line workers
  • The company has already received 105,000 face shield orders and is in discussions with major hospital groups who are interested in the product
  • Healthcare workers rely on equipment and uniforms to protect themselves against COVID-19
  • Allegra says it is monitoring its expenditure during these challenging times
  • The face shields are expected to give the company some extra cash in the hand
  • Allegra is down 23.1 per cent on the market today, trading for 15¢ apiece

Allegra Orthopaedics (AMT) has started distributing Australian made and designed face shields to front line workers.

The company has already received 105,000 face shield orders and is in discussions with major hospital groups who are interested in the product.

These face shields have been approved by the Therapeutic Goods Administration (TGA).

Allegra says it is monitoring its expenditure during these challenging times. The face shields are expected to give the company some extra cash in the hand as the Federal Government suspended all elective surgeries in public and private hospitals.

CEO Jenny Swain is proud to supply Australian designed and manufactured face shields to the front line carers.

“The current demand for PPE Illustrates the need for companies to be ready to diversify during this global uncertainty surrounding COVID-19,” she said.

“I am pleased to say that Allegra has been proactive in making this happen and more importantly, we are supporting Australian manufacturing,” she added.

Allegra is down 23.1 per cent on the market today, trading for 15¢ apiece at 1:54 pm AEST.

AMT by the numbers
More From The Market Online

This stock provides Oz’s only HIV self-test kit – and it’s bullish on the budget

Atomo Diagnostics is the only company in Australia that provides TGA-approved HIV self-test kits. It says…

Recce Pharma heading closer to full efficacy data for flagship R327

Recce Pharma has announced the latest cohort of patients in the company's Phase I/II UTI trial…
The Market Online Video

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

Race Oncology (ASX:RAC) has announced positive results in killing cancer cells in combination with the drug…

Optiscan agreement with Mayo Clinic aims to expedite robotic surgery

Optiscan Imaging is parterning with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system